Home » Topics » BioWorld Science

BioWorld Science
RSS

Solnatide approved for compassionate use in Austria for treatment of severe COVID-19

April 9, 2020

Novavax to initiate first-in-human studies of its new coronavirus candidate

April 9, 2020

Converting catch and release to PARP traps

April 9, 2020

Viriom opens phase II study of NNRTI elsulfavirine for COVID-19

April 8, 2020

GPR56 found to be tied with antidepressant treatment response

April 8, 2020

New HDAC6 inhibitors show promise in Charcot-Marie-Tooth disease cell model

April 8, 2020

Selective circadian regulation may yield new therapies

April 8, 2020

Kolon begins first-in-human study of KLS-2031 for neuropathic pain from lumbosacral radiculopathy

April 8, 2020

Emapalumab and anakinra studied to reduce hyperinflammation and respiratory distress in COVID-19

April 8, 2020

FDA clears Polaryx's IND for PLX-200 in juvenile neuronal ceroid lipofuscinosis

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...